glp 1 chicago GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Council on Science and Technology Can Microdose GLP-1 Agonists Help
Description
A 2018 meta-analysis found no favorable effect of DPP-4 inhibitors on all-cause mortality, cardiovascular mortality, myocardial infarction or stroke in patients with type 2 diabetes
If more than 4 days have elapsed, skip the missed dose and resume the regular schedule

Most can be managed with simple adjustments

GLP-1RAs have demonstrated potential in managing coexisting conditions associated with chronic inflammation, including obesity, dyslipidemia, and factors contributing to cardiovascular risk

Nonexpression of GLP-1R is common in advanced pancreatic tumors with lymphatic metastasis and is associated with poor prognosis, suggesting that GLP-1R may inhibit tumorigenesis and metastasis of human pancreatic cancer cells both in vitro and in vivo
